WASHINGTON (Reuters) – The U.S. Senate’s top Republican on Tuesday urged quick action on a bill to repeal Obamacare but stopped short of promising to bring it to the Senate floor for a vote, as the clock ticks down on the latest attempt to kill the 2010 healthcare law.
INDIANA, Pa./CHILLICOTHE, Ohio (Reuters) – As deaths mount in America’s opioid crisis, communities on the front lines face a hidden toll: the financial cost.
A family suffered from a mysterious, deadly insomnia for over 200 years. But one of them decided it was time to stop suffering in silence.
Caring for a chronically or terminally ill pet could be putting your own mental health at risk, a new paper suggests. Here are strategies that might help alleviate pet caregiver burden.
It’s a centuries old disorder that wasn’t recognized as worthy of research funding until 2005.
LONDON (Reuters) – The long-heralded threat of cut-price competition to its top-selling biological cancer medicines is finally becoming a reality for Roche, the world’s biggest maker of oncology treatments.
(Reuters) – U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer.
On the night before emergency workers had to evacuate people from a Florida nursing home where eight died, residents suffered in the sweltering heat as staff used fans to cool them, and one woman sat naked in a bed in a hallway, a video obtained by CNN shows.
BOSTON (Reuters) – The head of the U.S. Food and Drug Administration said on Friday the agency is working on a new policy that would encourage more compounding pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.